Single source: Childhood Cancer Survivor Study (U24 Clinical Trial Not Allowed)

Key facts

Copied from the official Grants.gov record. Last verified October 29, 2026.

Program name

Single source: Childhood Cancer Survivor Study (U24 Clinical Trial Not Allowed)

Issuing agency

National Institutes of Health (Department of Health and Human Services)

Opportunity number

RFA-CA-26-011

Funding type

Cooperative Agreement

Funding purpose

Health

Status

Forecasted

Application deadline

Forecasted · estimated close September 25, 2026 (agency estimate)

Agency estimates

Estimated posting: June 22, 2026. Estimated award date: July 1, 2027. Estimates can change.

Published award range

Not published by the agency

Cost sharing or match required

No

Eligible applicants (official categories)

• Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
• Others (see Additional Information on Eligibility)

Relevant to

NonprofitsHow we determined this: Grants.gov eligibility includes nonprofit organizations.

Geographic restrictions

None stated in structured data (federal opportunities are often nationwide). Check the eligibility details and full announcement for any limits.

Assistance Listing (CFDA)

93.395

Official source

View on Grants.gov ↗

Application URL

www.grants.gov/search-results-detail/361534 ↗Apply through Grants.gov (Workspace) using the application package on the official listing, unless the full announcement names a different submission system.

Source identifier

Grants.gov opportunity ID 361534 · Funding opportunity number RFA-CA-26-011

Posted

March 18, 2026 · Source last updated March 18, 2026

Last verified

October 29, 2026 (against Grants.gov)

Data completeness

92% of key fields published by the sourceNot published: published funding range.

Record confidence

mediumforecast — dates and amounts are agency estimates.

Eligibility details (from the agency)

This is a non-competitive funding opportunity intended to fund a single award. Through this single source, cooperative agreement Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) solicits an application to fund a single award to the current recipient of the Childhood Cancer Survivor Study.

Description (from the official listing)

Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) intends to support the continuation of the Childhood Cancer Survivor Study (CCSS) that investigates the long-term morbidity and mortality associated with cancer treatments. The CCSS represents a multi-institutional, multidisciplinary collaborative research resource that currently has health-related data from 38,000 or more 5-year survivors of pediatric and adolescent cancer patients with a comparison sibling control cohort. This NOFO seeks to obtain additional age-related longitudinal information from the current cohort of survivors and to include pediatric cancer survivors receiving modern therapies. The goal of the CCSS is to serve as a data resource and a biorepository for researchers. The objectives are to use the resources to conduct cancer risk assessments, observational and intervention-based research studies associated with long-term outcomes across the life span of survivors with the intent of improving cancer treatments. This is a Forecast for a single source that will invite application(s) from eligible organization(s) to apply. Please see the Eligibility Section for additional information. In accordance with NIH standard peer-review processes, the application(s) will be peer-reviewed, and only meritorious application(s) will be considered for funding.

Agency contact

NCI CCSS RFA
Email: NCICCSSRFA@mail.nih.gov